We are live on ! Find out more
BLFS icon

BioLife Solutions

66 hedge funds and large institutions have $154M invested in BioLife Solutions in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 7

167% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 9

70% more capital invested

Capital invested by funds: $90.5M → $154M (+$63.3M)

22% more funds holding

Funds holding: 5466 (+12)

5.43% more ownership

Funds ownership: 40.68%46.11% (+5.4%)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
66
Holders Change
+12
Holders Change %
+22.22%
% of All Funds
1.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
19
Increased
24
Reduced
9
Closed
7
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$1.25M +$1.11M +69,692 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.15M -$12.1K -761 -1%
PCM
28
Perkins Capital Management
Minnesota
$1.09M +$159K +10,000 +20%
QCMC
29
Quantum Capital Management (California)
California
$852K +$757K +47,619 New
Northern Trust
30
Northern Trust
Illinois
$829K -$53.6K -3,370 -7%
RC
31
Roubaix Capital
Colorado
$809K +$720K +45,245 New
Barclays
32
Barclays
United Kingdom
$807K -$442K -27,787 -38%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$716K
Marshall Wace
34
Marshall Wace
United Kingdom
$542K +$326K +20,512 +210%
Deutsche Bank
35
Deutsche Bank
Germany
$448K +$385K +24,176 +2,713%
ECM
36
ExodusPoint Capital Management
New York
$447K +$397K +24,987 New
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$401K +$119K +7,500 +50%
TEE
38
Tibra Equities Europe
United Kingdom
$395K +$351K +22,054 New
Janney Montgomery Scott
39
Janney Montgomery Scott
Pennsylvania
$378K +$9.54K +600 +3%
PWAM
40
Park West Asset Management
California
$367K +$326K +20,524 New
Citigroup
41
Citigroup
New York
$355K +$315K +19,819 New
State Street
42
State Street
Massachusetts
$346K +$34.3K +2,155 +13%
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$340K -$6.19K -389 -2%
WG
44
Winton Group
United Kingdom
$313K +$279K +17,511 New
MFG
45
Magnus Financial Group
New York
$307K +$273K +17,140 New
AA
46
Ancora Advisors
Ohio
$302K +$268K +16,880 New
BCM
47
BlueCrest Capital Management
Jersey
$291K +$74.7K +4,696 +41%
RG
48
Rathbones Group
United Kingdom
$259K
SKK
49
Shepherd Kaplan Krochuk
Massachusetts
$250K
CS
50
Cannell & Spears
New York
$243K +$216K +13,600 New

BLFS Hedge Fund Activity: Q1 2019 in Review

66 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q1 2019, worth a combined $154M — up 70% from $90.5M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new BLFS positions and 7 closed out — a net gain of 12 holders — while 24 added to existing stakes and 9 trimmed.

The largest buyer was Allianz Asset Management, opening a new position worth an estimated $3.19M. The largest seller was Renaissance Technologies, cutting an estimated $2.13M.

  • 66 institutional investors held BioLife Solutions (BLFS) as of Q1 2019, up from 54 in Q4 2018.
  • Funds reported $154M of BioLife Solutions stock for Q1 2019, up 70% quarter-over-quarter.
  • 19 funds opened new BioLife Solutions positions in Q1 2019 and 7 closed out, a net change of +12 holders.
  • The largest BioLife Solutions buyer in Q1 2019 was Allianz Asset Management, an estimated $3.19M added.
  • The largest BioLife Solutions seller in Q1 2019 was Renaissance Technologies, an estimated $2.13M sold.

Based on aggregated 13F filings for Q1 2019.